EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease

Stephan Schnizler, Michael Naumann, Michael Vieth

Histochemistry and Cell Biology · 2025

DOI: 10.1007/s00418-024-02345-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histochemistry and Cell Biology, 2025. Verfasst von Stephan Schnizler und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Klinikum Bayreuth, 95445, Bayreuth, Germany. Hauptthemen laut MEDLINE: Tumor Necrosis Factor alpha-Induced Protein 3. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A20, an ubiquitin-editing enzyme, plays a pivotal role in regulating cell signaling and immune responses. Dysregulated A20 expression has been associated with various pathological conditions, including inflammatory diseases and malignancies, where its expression levels often correlate with differing prognoses in solid tumors. This study aimed to explore the expression and cellular localization of A20 in both nonpathological and diseased human gastric tissues to gain deeper insights into its involvement in gastric pathologies. We analyzed paraffin-embedded gastric tissue samples from 326 patients. A20 expression was assessed using immunohistochemistry (IHC) with results categorized according to the Remmele and Stegner immunoreactive score (IRS). The study compared A20 expression across a spectrum of gastric pathologies, including Helicobacter pylori (HP) gastritis, autoimmune gastritis (A-gastritis), reactive gastropathy (C-gastritis), Ex-HP-gastritis, adenomas, and adenocarcinomas, with nonpathological gastric mucosa serving as a baseline. Our findings demonstrate a significant increase in A20 expression in HP-gastritis ( p = 0.019), A-gastritis ( p = 0.001), adenomas ( p < 0.001), and adenocarcinomas ( p < 0.001). Conversely, no significant differences in A20 expression were observed in C-gastritis or Ex-HP-gastritis cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor alpha-Induced Protein 3HumansFemaleMaleMiddle AgedBiopsyGastric MucosaAdultAgedSeverity of Illness IndexStomach NeoplasmsGastritisImmunohistochemistry

Stichwörter der Autor:innen

Helicobacter B-type gastritisA20Gastric adenocarcinomaGastric mucosaNF-kB

Substanzen

Tumor Necrosis Factor alpha-Induced Protein 3TNFAIP3 protein, human

Autor:innen und Institutionen

  • Institute of Pathology, Klinikum Bayreuth, 95445, Bayreuth, Germany.
  • Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054, Erlangen, Germany.
  • Institute of Pathology, Klinikum Bayreuth, 95445, Bayreuth, Germany. naumann@med.ovgu.de.
  • Institute of Experimental Internal Medicine, Otto-Von-Guericke-Universität Magdeburg, 39120, Magdeburg, Germany. naumann@med.ovgu.de.

Zitieren

APA

Schnizler, S., Naumann, M., & Vieth, M. (2025). Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease. Histochemistry and Cell Biology. https://doi.org/10.1007/s00418-024-02345-2

Vancouver

Schnizler S, Naumann M, Vieth M. Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease. Histochemistry and Cell Biology. 2025. doi:10.1007/s00418-024-02345-2

BibTeX
@article{Schnizler2025,
  author = {Schnizler, Stephan and Naumann, Michael and Vieth, Michael},
  title = {Differential expression of the ubiquitin-editing enzyme A20 in gastric biopsies indicates the severity of disease},
  journal = {Histochemistry and Cell Biology},
  year = {2025},
  doi = {10.1007/s00418-024-02345-2}
}
Kostenlos starten →